TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
NKTR

Nektar Therapeutics

Healthcare · Biotechnology

60.40$ +5.9% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for Nektar Therapeutics (NKTR): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 23 · -18.8 % 23 Q4 23 · -4.8 % 23 Q1 24 · 10.1 % 24 Q2 24 · 6.6 % 24 Q3 24 · 14.2 % 24 Q4 24 · -15.4 % 24 Q1 25 · -28.0 % 25 Q2 25 · 5.8 % 25 Q3 25 · 33.0 % 25 Q4 25 · 63.1 % 25 Q1 26 · -20.3 % 26 Q2 26 · 40.3 % 26

EPS estimate beaten

Full history 86 of 124 quarters (69%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/25/2026 NEKTAR THERAPEUTICS (NKTR): Other Events · sec.gov Open ↗
  • 09/08/2026 NEKTAR THERAPEUTICS (NKTR): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/13/2026 NEKTAR THERAPEUTICS (NKTR): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?